Aimei Health extends SPAC merger deadline to Oct 6
Aimei Health Technology Co., Ltd. (AFJK) extended the deadline to complete its initial business combination by one month, making a payment of $34,330.96 into its trust account to move the Termination Date from September 6, 2026 to October 6, 2026.
Rhea-AI Filing Summary
Aimei Health Technology Co., Ltd. (AFJK) extended the deadline to complete its initial business combination by one month, making a payment of $34,330.96 into its trust account to move the Termination Date from September 6, 2026 to October 6, 2026. This amount represents the lesser of $80,000 for all outstanding public shares and $0.033 per outstanding public share for the monthly extension and is the 22nd extension permitted under its Amended and Restated Articles of Association.
To fund the extension payment, the company issued an unsecured Promissory Note for $34,330.96 to Aimei Investment Ltd. The note bears no interest and becomes due upon consummation of the planned business combination with United Hydrogen. The payee may convert the note into private units at $10.00 per unit, each unit consisting of one ordinary share and one right to receive one-fifth of one ordinary share, immediately prior to closing by giving two business days’ written notice.
Positive
- None.
Negative
- None.
8-K Event Classification
Key Figures
Key Terms
trust account financial
Promissory Note financial
Termination Date financial
business combination financial
private units financial
FAQ
What did AFJK disclose about its latest SPAC extension on September 3, 2026?
How much did AFJK contribute to the trust account for this extension?
What is the new Termination Date for AFJK’s initial business combination?
What are the key terms of AFJK’s $34,330.96 Promissory Note?
Can the AFJK promissory note be converted into equity and on what terms?
Who is the counterparty to AFJK’s business combination referenced in this filing?
AI-generated analysis. How Rhea-AI works. Not financial advice.